Healthcare >> CEO Interviews >> April 26, 2005
DR. SIMON NEIL PIMSTONE is a Founder, Director, President and Chief
Executive Officer at Xenon Pharmaceuticals Inc. Dr. Pimstone received
his MD from the University of Cape Town. He is an internal medicine
specialist with an interest in cardiovascular disease. Prior to his
specialization, he trained as a Clinical Research Fellow with the
Department of Medical Genetics at the University of British Columbia and
obtained his PhD through the University of Amsterdam in cardiovascular
genetics. Dr. Pimstone has served as a consultant physician at the St.
Paul's Hospital Lipid Clinic in Vancouver, and he is a Director of the
Providence Healthcare Research Trust, a Director of the AllerGEN
National Centre of Excellence and he is an Advisory Member of the SFU
Biotech MBA program. Dr. Pimstone is a member of the Young Presidents'
Organization and has received the Business in Vancouver Top 40 under 40
Award in 2005. Dr. Pimstone is the author of numerous peer-reviewed
publications and is also a regular guest speaker at international
scientific meetings and healthcare conferences. Profile
Dr. Pimstone: Xenon is five years young and had its first angel
financing in late 1999. The company has made some
